J&J to Pay $5.5 Billion to Settle Talc-Related Cancer Claims

Johnson & Johnson on Monday said it agreed to a $5.5 billion commitment to resolve years of litigation related to claims that its talc products caused ovarian cancer. The drugmaker said the proposed resolution represents “an efficient conclusion” to the …

Read the full article →

Share:

More Posts

Send Us A Message